RT Journal Article
SR Electronic
T1 Regional healthy brain activity, glioma occurrence and symptomatology
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.14.22269290
DO 10.1101/2022.01.14.22269290
A1 Tianne Numan
A1 Lucas C. Breedt
A1 Bernardo de A.P.C. Maciel
A1 Shanna D. Kulik
A1 Jolanda Derks
A1 Menno M. Schoonheim
A1 Martin Klein
A1 Philip C. de Witt Hamer
A1 Julie J. Miller
A1 Elizabeth R. Gerstner
A1 Steven M. Stufflebeam
A1 Arjan Hillebrand
A1 Cornelis J. Stam
A1 Jeroen J.G. Geurts
A1 Jaap C. Reijneveld
A1 Linda Douw
YR 2022
UL http://medrxiv.org/content/early/2022/01/28/2022.01.14.22269290.abstract
AB It is unclear why exactly gliomas show preferential occurrence in certain brain areas. Increased spiking activity around gliomas leads to faster tumor growth in animal models, while higher non-invasively measured brain activity is related to shorter survival in patients. However, it is unknown how regional intrinsic brain activity, as measured in healthy controls, relates to glioma occurrence. We first investigated whether gliomas occur more frequently in regions with intrinsically higher brain activity. Secondly, we explored whether intrinsic cortical activity at individual patients’ tumor locations relates to tumor and patient characteristics.Across three cross-sectional cohorts, 306 patients with different tumor subtypes were included. Tumor masks were created for each patient. Intrinsic regional brain activity was assessed through resting-state magnetoencephalography (MEG) acquired in healthy controls, which was then source-localized to 210 cortical brain regions according to the Brainnetome atlas. Brain activity was operationalized as (1) broadband power and (2) offset of the aperiodic component of the power spectrum, which both reflect neuronal spiking of the underlying neuronal population. We additionally assessed (3) the slope of the aperiodic component of the power spectrum, which is thought to reflect the neuronal excitation/inhibition (E/I) balance. First, correlation coefficients were calculated between group-level regional glioma occurrence, as obtained by concatenating tumor masks across patients, and group-averaged regional intrinsic brain activity. Second, intrinsic brain activity at specific tumor locations was calculated by overlaying patients’ individual tumor masks with regional intrinsic brain activity of the controls and was associated with tumor and patient characteristics.As hypothesized, more malignant glioma preferentially occurred in brain regions characterized by higher intrinsic brain activity in controls as reflected by higher offset. Secondly, intrinsic brain activity at patients’ individual tumor locations differed according to glioma subtype and performance status: the most malignant IDH-wildtype glioblastoma patients had the lowest E/I balance at their individual tumor locations, while lower E/I balance weakly related to poorer Karnofsky performance status, independent of glioma subtype.In conclusion, malignant gliomas more frequently occur in cortical brain regions with intrinsically higher activity levels, suggesting that more active regions are more vulnerable to glioma development. Moreover, indices of healthy, intrinsic E/I balance at patients’ individual tumor locations may capture both tumor biology and patients’ performance status. These findings contribute to our understanding of the complex and bidirectional relationship between normal brain functioning and glioma growth, which is at the core of the relatively new field of ‘cancer neuroscience’.Competing Interest StatementThe authors have declared no competing interest.Funding StatementPart of the data collection was funded by the Netherlands Organization for Scientific Research (Rubicon grant, Veni grant 91614986, Vidi grant 198.015) and the Branco Weiss Fellowship.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:VU University Medical Center Medical Ethical Committee, Dana Farber Cancer Institute Institutional Review BoardI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe derivative data and code used in this manuscript are available. https://github.com/multinetlab-amsterdam/projects/ Bbpbroadband powerLENSgLioma-spEcific braiN activity SignatureMEGMagnetoencephalography